Needlestick Safety and Prevention Law Frequently Asked Questions & Answers


On
November 6, 2000, the Needlestick Safety and Prevention Act was
signed into law. The new compliance deadline, mandated by this law
has been moved to April 18, 2001. In an effort to assist your healthcare
facility in understanding and complying to the law, BD has developed
the following Frequently Asked Questions.

In short, what does the new legislation accomplish?
The new legislation serves to reinforce the BBP standard preventing legal challenges to the
November 5, 1999 Federal OSHA Compliance Directive.

Is this directive enforceable? How?
Yes. It will be enforced through the traditional OSHA inspection procedures. Employers are subject to monetary fines for
violating the BBP standard.
Citations can be issued for:
Failure to have an Exposure Control Plan.
Failure to review and implement commercially available "safer medical devices."
Failure to include procedures for documenting exposure incidents.
Failure to review and update plan at least annually.
Failure to follow universal precautions.
Failure to comply with most current CDC recommendations for post-exposure evaluation and follow-up.

Exactly what medical procedures require the use of "safer medical devices"?
Any time a healthcare worker may be exposed to blood or other potentially infectious material, the employer must evaluate
and implement safer medical devices that eliminate exposures to the lowest feasible extent.

What are engineering controls"?
The term "engineering controls" is now defined and means
controls that isolate or remove the BBP hazard from the
workplace. They are described as "safer medical devices used
to prevent percutaneous injuries before, during or after use
through safer design features." Examples include needleless
devices, shielded needle devices, blunt needles, plastic capillary
tubes.

Is a specific product technology or brand recommended in the revised regulation?
No. As OSHA states in the Compliance Directive, "OSHA does
not advocate the use of one particular device over another."

When does the new legislation take effect?
Federal Bill HR 5178 was signed into law by President
Clinton on November 6, 2000. Publication of the legislation
in the Federal Register took place on January 18,
2001, resulting in an April 18, 2001 compliance date.
Please be mindful that throughout this time and until
the time the legislation takes effect, the Federal OSHA
Compliance Directive of November 5, 1999 remains in
effect and fines are enforceable.

So, when do I have to be in compliance?
April 18, 2001.

What do I have to do to be in compliance?
Update or create a BBP Exposure Control Plan.
Evaluate and implement "safer medical devices" where they are found to be effective in eliminating or minimizing occupational exposures. Frontline healthcare workers are to be part of the evaluation and selection process.
Continuously monitor the effectiveness of engineering controls.
Update employee training to include training on HCV and the use of "safer medical devices."
Review new Compliance Directive to determine other specific changes necessary for the needs of your facility.

Who has to comply?
Hospitals, alternate site facilities, clinical laboratories and
other facilities where employees may be exposed to blood or
other potentially infectious material are covered by the BBP
standard. Special rules apply in home health services and to
personnel service firms that supply contract workers to hospitals
and other healthcare facilities.

Are there any "loopholes" or exceptions to the use of "safer medical devices"?
There is no list of exceptions. Employers must review and
consider commercially available devices to determine
whether they are effective in reducing occupational exposures
to the lowest feasible extent.

For additional information, what are the website addresses of OSHA, CDC and NIOSH?
CDC and NIOSH: www.cdc.gov/niosh
Federal OSHA: www.osha.gov
For additional information regarding the Needle Safety and Prevention Law,
contact your local BD Sales Consultant.
|